A. Staebler

Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome

K. Schenke-Layland, A. Hartkopf, M. Templin, 2022, bioRxiv.

RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy.

C. Denkert, M. Dietel, J. Budczies, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Prevalence and distribution pattern of nodal metastases in advanced ovarian cancer.

D. Wallwiener, F. Fend, S. Brucker, 2016, Molecular and clinical oncology.

The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer

D. Wallwiener, E. Grischke, S. Brucker, 2015, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

RETRACTED ARTICLE: The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer

D. Wallwiener, F. Fend, E. Grischke, 2015, Journal of Cancer Research and Clinical Oncology.

Role of Pelvic and Para-aortic Lymph Node Metastases in Optimally Cytoreduced Advanced Ovarian Cancer.

D. Wallwiener, F. Fend, E. Grischke, 2015, Anticancer research.

Detection of nonpigmented endometriotic lesions with 5-aminolevulinic acid-induced fluorescence.

L. Kiesel, P. Wülfing, O. Buchweitz, 2004, The Journal of the American Association of Gynecologic Laparoscopists.

Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database

A. Hasenburg, F. Heitz, P. Harter, 2022, Archives of Gynecology and Obstetrics.

Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial.

T. Fehm, J. Heil, T. Kühn, 2017, Breast.

Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer

G. Henke, M. Weinmann, G. Henke, 2012, Strahlentherapie und Onkologie.

Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial.

T. Fehm, J. Heil, T. Kühn, 2017, Breast.